Xiong Wenqian, Liu Yi, Zhang Ling, Yang Chun
Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Int J Womens Health. 2025 May 31;17:1605-1614. doi: 10.2147/IJWH.S521964. eCollection 2025.
Endometrial thickness measurement (EMT) is not a reliable predictor of clinical pregnancy in Asherman syndrome (AS) patients. The aim of this study is to investigate the impact of endometrial patterns on reproductive outcomes in patients with AS for both fresh and frozen embryo transfers. Additionally, it is essential to determine the preferred endometrial preparation protocol for women in this population who are planning frozen embryo transfer (FET).
Seventy-six patients diagnosed with Asherman syndrome underwent hysteroscopic adhesiolysis followed by in vitro fertilization-embryo transfer (IVF-ET) at Union Hospital of Huazhong University of Science and Technology between February 2019 and July 2021. This study reviewed the endometrial patterns of 134 embryo transfers and the endometrial preparation protocols of 127 frozen embryo transfer (FET) cycles within this cohort of patients.
The triple-line endometrial pattern before embryo transfer (ET) was found to be a significant predictor of a positive clinical pregnancy outcome (odds ratio 0.315, P = 0.007) and a successful live birth (odds ratio 0.306, P = 0.009). Moreover, the gonadotropin-releasing hormone agonist (GnRHa) downregulation in conjunction with hormone replacement therapy (HRT) protocol showed improvements in both the clinical pregnancy rate (odds ratio 0.218, P = 0.005) and live birth rate (odds ratio 0.362, P = 0.049) compared to the HRT protocol in FET cycles.
A triple-line endometrial pattern before embryo transfer is associated with successful clinical pregnancy and live birth in AS patients undergoing IVF. Additionally, the GnRHa+HRT protocol may increase the clinical pregnancy and live birth rates in AS women undergoing FET cycles.
子宫内膜厚度测量(EMT)并非阿谢曼综合征(AS)患者临床妊娠的可靠预测指标。本研究旨在探讨子宫内膜形态对AS患者新鲜胚胎移植和冷冻胚胎移植生殖结局的影响。此外,对于计划进行冷冻胚胎移植(FET)的该人群女性,确定首选的子宫内膜准备方案至关重要。
2019年2月至2021年7月期间,76例诊断为阿谢曼综合征的患者在华中科技大学附属协和医院接受了宫腔镜粘连松解术,随后进行体外受精-胚胎移植(IVF-ET)。本研究回顾了该队列患者中134次胚胎移植的子宫内膜形态和127个冷冻胚胎移植(FET)周期的子宫内膜准备方案。
发现胚胎移植(ET)前的三线子宫内膜形态是临床妊娠阳性结局(优势比0.315,P = 0.007)和成功活产(优势比0.306,P = 0.009)的重要预测指标。此外,与FET周期中的激素替代疗法(HRT)方案相比,促性腺激素释放激素激动剂(GnRHa)下调联合HRT方案在临床妊娠率(优势比0.218,P = 0.005)和活产率(优势比0.362,P = 0.049)方面均有改善。
胚胎移植前的三线子宫内膜形态与接受IVF的AS患者临床妊娠成功和活产相关。此外,GnRHa+HRT方案可能会提高接受FET周期的AS女性的临床妊娠率和活产率。